Fresh frozen plasma, fibrinogen concentrate, and antithrombin concentrate administration for obstetrical disseminated intravascular coagulation by the Japanese previous and new criteria
- 29 January 2025
- journal article
- research article
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (2) , e16220
Abstract
Aim: The purpose of this study is to clarify the frequencies of fresh frozen plasma (FFP) ± fibrinogen concentrate administration (fibrinogen concentrate [FC] therapy) and antithrombin (AT) concentrate administration (AT therapy) for the women with obstetrical disseminated intravascular coagulation (DIC).Methods: Two retrospective multicenter case–control studies as Study‐1 (January–December 2018) and Study‐2 (July 2022–June 2023) were conducted. Study‐1 was the historical control of Study‐2. All participants experienced a blood loss of ≥1000 mL during vaginal delivery or ≥2000 mL during cesarean section. All participants were subsequently assigned to the DIC group or non‐DIC group.Results: Study‐1 comprised 175 women (obstetrical DIC, 27; control, 148; by the previous criteria) and Study‐2 comprised 175 women (obstetrical DIC, 9; control, 166; by the new criteria). The frequencies of FFP (±FC therapy) or FC therapy in DIC group were significantly higher than non‐DIC group in Study‐1 (88.9% vs. 25.0%, 44.4% vs. 4.0%) and Study‐2 (100% vs. 24.7%, 77.8% vs. 5.4%); however, the frequencies of AT therapy were similar. Furthermore, in the DIC group, all women with fibrinogen n = 19) and Study‐2 (n = 8); however, those with AT activity <70% received AT therapy (16.7% [4/24] and 12.5% [1/8], respectively).Conclusion: We revealed an association between the high frequency of FFP ± FC therapy and lower fibrinogen levels, but a low frequency of AT therapy regardless of AT activity, in obstetrical DIC regardless of diagnosis criteria.Keywords
Funding Information
- Japan Blood Products Organization
This publication has 17 references indexed in Scilit:
- Effectiveness, reliability, and validity of new Japanese diagnostic criteria for obstetrical disseminated intravascular coagulationScientific Reports, 2024
- Changes in use and outcomes after fibrinogen concentrate insurance coverage for critical obstetrical hemorrhage: a nationwide questionnaire survey in JapanScientific Reports, 2024
- Differences between Japanese new criteria and pregnancy-specific modified ISTH DIC scores for obstetrical DIC diagnosisInternational Journal of Hematology, 2024
- Effect of hypofibrinogenemia on obstetrical disseminated intravascular coagulation in Japan in 2018: a multicenter retrospective cohort studyInternational Journal of Hematology, 2021
- An algorithm for the management of coagulopathy from postpartum hemorrhage, using fibrinogen concentrate as first-line therapyInternational Journal of Obstetric Anesthesia, 2017
- The Clinical Efficacy of Fibrinogen Concentrate in Massive Obstetric Haemorrhage with HypofibrinogenaemiaScientific Reports, 2017
- Antithrombin III for critically ill patientsCochrane Database of Systematic Reviews, 2016
- Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and managementAmerican Journal of Obstetrics and Gynecology, 2015
- Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trialBritish Journal of Anaesthesia, 2015
- Diagnosis and Management of Acute Obstetrical DICSeminars in Thrombosis and Hemostasis, 2001